INTRODUCTION
============

Spray-dried plasma (**SDP**) is an ingredient that, when included in the diet of weanling pigs, improved daily gain, feed intake, and feed efficiency, and reduced the extent and severity of diarrhea ([@COFFEY-AND-CROMWELL-2001]; [@VAN-DIJK-ETAL-2001]). Numerous studies involving challenges with pathogenic bacteria (*Escherichia coli, Salmonella, Pasteurella multocida*), viruses (rotavirus, coronavirus, white spot syndrome virus), or protozoa (*Cryptosporidium parvum*) demonstrated reduced mortality and morbidity when feeding spray-dried bovine or porcine plasma to various animal species, indicating that plasma supplements can be considered as an alternative to the use of antibiotics ([@QUIGLEY-AND-DREW-2000]; [@BIKKER-ETAL-2004]; [@CAMPBELL-ETAL-2004]; [@TORRALLARDONA-ETAL-2007]).

In an epidemiological study of Canadian swine farms, feeding SDP was associated with reduced mortality due to porcine reproductive and respiratory syndrome and porcine circovirus type 2 ([@DEWEY-ETAL-2006]). A protein fraction isolated from bovine plasma containing approximately 50% IgG consumed orally has been shown to improve viral gastroenteritis in children ([@GUARINO-ETAL-1994]) and has been used in the treatment of diarrhea in acquired immune deficiency syndrome patients infected with *C. parvum* ([@GREENBERG-AND-CELLO-1996]). It has been speculated that IgG is responsible for the SDP effect (van Djik et al., 2001). However, over 250 peptides have been identified in human plasma ([@ANDERSON-AND-ANDERSON-2002]). Many proteins in SDP were shown to retain biological function after spray drying ([@BORG-ETAL-2002]). Although it is logical that IgG contributes to the effects of SDP, it is also likely that many of the other plasma compounds also contribute to the various responses that have been attributed to the oral consumption of SDP.

To better understand the effects of SDP on the intestinal immune system and on intestinal barrier function, a series of experiments was conducted utilizing a rat model of mild intestinal inflammation. The model is based on the systemic administration of *Staphylococcus aureus* enterotoxin B (**SEB**), an enterotoxin that activates the mucosal immune system affecting both organized and diffuse gut-associated lymphoid tissue (**GALT**). Staphylococcal enterotoxin B also increases mucosal permeability, increases luminal water secretion, and reduces the absorption of glucose across the small intestine. Our main interest was to better understand the mechanism of action of SDP at the mucosal level and potential modulation of the intestinal inflammatory responses. A second objective was to compare the effects of SDP with a full plasma protein fraction (**PPF**) isolated from plasma containing approximately 50% IgG (plasma with fibrin and albumin mostly removed).

INTESTINAL IMMUNE SYSTEM
========================

The immune response is divided into innate and acquired immunity. Innate immunity consists of those functions that are nonspecific in nature and with which the host is born. The innate immune system acts as a first line of defense by preventing the entry of infectious agents or by eliminating invading pathogens. It comprises physical barriers (e.g., skin or mucous membranes), cells in blood and tissues (e.g., phagocytes and natural killer cells), and soluble mediators (e.g., complement proteins and cytokines). While protection by innate immunity is effective, some pathogens have developed the ability to escape detection or clearance by this system, leading to the activation of the acquired immune system. This system consists of 2 major cell types, the T- and B-lymphocytes, which enable the specific recognition of and response to invaders. The T-lymphocytes mediate mainly cellular acquired immunity, whereas B lymphocytes are involved in humoral acquired immunity ([@JANEWAY-2001]).

The largest immune organ is situated in the gut where the mucosal immune system interacts with host and intestinal microbiota, playing an important role in protecting against pathogenic microorganisms. The mucosal immune system maintains homeostasis by innate and acquired immunity along the epithelial surface ([@KIYONO-AND-FUKUYAMA-2004]). Gut-associated lymphoid tissue accounts for up to 80% of the mucosal immune system and is distributed throughout the intestine as organized entities, including Peyer\'s patches, isolated follicles, and mesenteric lymph nodes, or as diffuse GALT consisting of lymphocytes scattered along the epithelium and the lamina propria ([@GRANGER-ETAL-2006]). Both compartments are part of a regulatory system with specific roles; organized GALT is the inductor site of the immune response and diffuse GALT is the effector site.

The primary role of the immune response is to recognize, destroy, and eliminate antigens and pathogens. However, if the immune system is stimulated and the response is not controlled, it can lead to tissue damage and pathology ([@MCKAY-ETAL-1998]). In addition, stimulation of the immune system shifts available energy and nutrients from growth and other productive functions and diverts them to support the immune system ([@DEMAS-ETAL-1997]; [@JOHNSON-1997]; [@KLASING-AND-KORVER-1997]).

The results described in this review were obtained from a rat model of mild intestinal inflammation induced by SEB. Wistar-Lewis rats receive an intraperitoneal injection of SEB on d 30 and 33 of age resulting in intestinal inflammation characterized by activation of T helper lymphocytes and an increase of several cell populations involved in inflammatory states ([@PEREZ-BOSQUE-ETAL-2004], [@PEREZ-BOSQUE-ETAL-2008B]). In all experiments, animals were assigned to dietary treatment at weaning (d 21) and continued until d 35, when they were killed.

Staphylococcal enterotoxin B induced recruitment of immune cells belonging to the innate immune system, neutrophils ([@PEREZ-BOSQUE-ETAL-2004]) and eosinophils (M. Moretó and A. Pérez-Bosque, unpublished results). Addition of SDP to the diet did not modify the SEB-induced effects on neutrophil infiltration, but reduced eosinophil infiltration and the degree of degranulation ([Figure 1](#F1){ref-type="fig"}). Dietary supplementation with SDP or PPF prevented the SEB-induced activation of CD4 cells (i.e., T-helper lymphocytes) in Peyer\'s patches, and in the lamina propria and intraepithelial compartments ([@PEREZ-BOSQUE-ETAL-2004], [@PEREZ-BOSQUE-ETAL-2008B]; [Figure 2](#F2){ref-type="fig"}). These results indicate that feeding rats with SDP or PPF reduces the SEB-induced activation of T-helper cells. Activation of T-helper lymphocyte produces a cytokine release that amplifies the innate and the acquired immune system ([@MOWAT-2003]).

![Effects of dietary supplementation with plasma concentrate (spray-dried plasma, SDP) and plasma protein fraction (PPF) obtained from porcine blood, on lamina propria eosinophils in a rat model of mild intestinal inflammation. Panel A shows the effect on cell number. Panel B shows the effects on eosinophil activation as indicated by the degree of degranulation. Inflammation was induced by intraperitoneal administration of 50 μ g of *Staphylococcus aureus* enterotoxin B (SEB) on d 30 and 33 of age. Animals were fed experimental diets for 14 d. Results are mean ± SEM of 5 animals. Symbols indicate significant differences (*P* \< 0.05): \*vs. control group; §vs. SEB group (unpublished data).](jas1381-f1){#F1}

![Effects of dietary supplementation with plasma concentrate (spray-dried plasma, SDP) and the plasma protein fraction (PPF) on activated T lymphocytes and cytotoxic cell populations in Peyer\'s patches (PP; panel A) and lamina propria (LP; panel B) in a rat model of mild intestinal inflammation. Inflammation was induced by intraperitoneal administration of 50 μ g of *Staphylococcus aureus* enterotoxin B (SEB) on d 30 and 33 of age. Animals were fed experimental diets for 14 d. The CD25 (activated T lymphocytes), CD25/CD4 (as the fraction of activated T helper lymphocytes), CD25/CD8 (as the fraction of activated suppressor/cytotoxic T lymphocytes), natural killer (NK) cells, and δγ-T cells (T lymphocytes that express the δγ-T cell receptor) as percentages respect to total number of lymphocytes (A) and as number of cells per mm^2^ (B). Results are mean ± SEM of 8 to 10 animals in PP and 5 to 8 animals in LP. Symbols indicate significant differences (*P* \< 0.05): \*vs. control group; §vs. SEB group (from [@PEREZ-BOSQUE-ETAL-2004], [@PEREZ-BOSQUE-ETAL-2008B]).](jas1381-f2){#F2}

The δγ-T cell subset modulates the inflammatory response by promoting influx of lymphocytes and monocytes to mucosal surfaces ([@SOLTYS-AND-QUINN-1999]). Staphylococcal enterotoxin B administration increased the δγ-T lymphocyte population in Peyer\'s patches, lamina propria, and intraepithelial lymphocytes. Plasma protein prevents the increase in the δγ-T lymphocytes in Peyer\'s patches and in lamina propria, which supports the hypothesis that a SDP-supplemented diet can play a role in the modulation of the immune response. In contrast, the PPF supplement only prevented the SEB effects in the lamina propria ([@PEREZ-BOSQUE-ETAL-2004], [@PEREZ-BOSQUE-ETAL-2008B]).

[@NOFRARIAS-ETAL-2006] reported similar results from studies with pigs, showing that SDP can reduce the number of δγ-T cells in ileocolic lymph nodes and decrease leukocyte infiltration in intestinal mucosa. These findings agree with the decreased cell density in intra-villous lamina propria described by [@JIANG-ETAL-2000]. [@NOFRARIAS-ETAL-2006] found evidence that the effects of SDP on GALT were also observable in nonchallenged pigs at weaning, a stressful event involving complex social, environmental, and nutritional changes for piglets ([@PLUSKE-ETAL-1997]) that is associated with intestinal and systemic inflammatory responses ([@MCCRACKEN-ETAL-1999]; [@JIANG-ETAL-2000]; [@PIE-ETAL-2004]).

The release of numerous proinflammatory cytokines is upregulated in response to an infection. These proinflammatory cytokines behave as chemoattractants and induce expression of adhesion molecules, which favors localization of immune cells responding to infection. In addition, cytokines stimulate functional maturation of immune cells, enabling their response to (or recognition of) pathogens. To balance the proinflammatory cytokines, a group of antiinflammatory cytokines dampens the immune response to prevent injury to the host by its own immune system ([@LIPPOLIS-2008]).

In the mild intestinal inflammation rat model, SEB administration increased the release of tumor necrosis factor-α (**TNF-**α) and interferon-γ (**IFN-**γ) in the jejunal mucosa ([@MORETO-ETAL-2008]). Both SDP and PPF prevented the effects of SEB on the release of proinflammatory cytokines, indicating that the effects of plasma supplements during an inflammatory event involve changes in the mucosal cytokine balance. [@BOSI-ETAL-2004] also showed that SDP can reduce proinflammatory cytokine expression in the gut of early weaned piglets challenged with enterotoxigenic *E. coli* K88. Both observations are consistent with the view that SDP can limit the production of cytokines by modulating the immune response.

Immunosuppressive functions are also attributed to regulatory T-cells (T-reg lymphocytes) with a cytokine profile distinct from either Th1 or Th2 cells (e.g., transforming growth factor-β and IL-10). After antigenic stimulation, T-reg lymphocytes can specifically inhibit the immune response of T-helper cells ([@IIJIMA-ETAL-2001]; [@JANEWAY-2001]). Recent results in our laboratory showed that SDP supplementation increased IL-10 production in SEB-challenged rats at the intestinal (Peyer\'s patches and intestinal mucosa) as well as at the systemic level ([@MORETO-ETAL-2008]). These results support the view that the mechanism of action of SDP involves modulating the immune response to toxins and other pathogenic agents by regulating the balance of proinflammatory and antiinflammatory cytokines.

BARRIER FUNCTION
================

A key function of the intestinal epithelium is to serve as a selective barrier allowing the uptake of nutrients while excluding toxins and microorganisms. However, the epithelium is not completely impermeable to luminal contents, and for this reason, the mucosal to serosal movement of solvents and solutes is closely regulated. Mucosal permeability mainly depends on the capacity of tight junctions to efficiently seal the apical poles of epithelial cells. The space between cells is occupied by interlocking proteins, called claudins, that bind scaffolding proteins, such as ZO-1, which in turn link them to the cellular cytoskeleton ([@BARRETT-2008]). An acute change of the intestinal barrier function contributes to disease pathogenesis, especially when the intestine is challenged by luminal antigens.

Permeability of the intestinal epithelium is regulated by several stimuli. Increased permeability is associated with secretory diarrhea ([@TOIVOLA-ETAL-2004]). Toxins from *Clostridium* and *Vibrio* change the localization of several tight junction proteins ([@CHEN-ETAL-2002]) or reduce the number of strands in the tight junction ([@SONODA-ETAL-1999]). Moreover, enterotoxins can also have indirect effects by inducing the release of proinflammatory cytokines, such as INF-γ and TNF-α. Both cytokines increase epithelial permeability by reducing the expression of ZO-1 and occludin ([@TSUKITA-ETAL-2002]; [@BRUEWER-ETAL-2003]). Staphylococcal enterotoxin B can also stimulate the secretion of IFN-γ and TNF-α from lymphocytes, which can disassemble tight junction protein complexes and enhance paracellular permeability of micro vascular endothelial cells ([@NUSRAT-ETAL-2000]).

We observed that SEB increases luminal water contents, indicating an effect of SEB on the absorptive and secretory water balance ([@PEREZ-BOSQUE-ETAL-2004]). [Figure 3](#F3){ref-type="fig"} shows that dietary supplementation with SDP and PPF prevented the effect of the enterotoxin 24 h after the second SEB dose and that SDP was still effective after 48 h. Other studies performed with plasma supplements showed positive health effects; for example, oral supplementation of calves with bovine serum ameliorated *C. parvum*-induced diarrhea ([@HUNT-ETAL-2002]) and decreased the severity of disease in young calves exposed to coronavirus ([@ARTHINGTON-ETAL-2002]).

![Effects of dietary supplementation with plasma concentrate (spray-dried plasma, SDP) and plasma protein fraction (PPF) on water content in feces (expressed as percentage of wet weight) in a rat model of mild intestinal inflammation. Inflammation was induced by intraperitoneal administration of 50 μ g of *Staphylococcus aureus* enterotoxin B (SEB) on d 30 and 33 of age. Animals were fed experimental diets for 14 d. Results are mean ± SEM of 8 to 10 animals. Symbols indicate significant differences (*P* \< 0.05): \*vs. control group; §vs. SEB group (from [@PEREZ-BOSQUE-ETAL-2006]).](jas1381-f3){#F3}

Increased luminal water may be secondary to changes in luminal osmolality (e.g., due to reduced nutrient absorption or secretion) or to changes in mucosal permeability. Because the effects on the absorption of glucose and amino acids are small (see discussion below), we wanted to know if these effects on luminal water contents could be explained by changes in paracellular permeability. To this end, we measured the transmural flux of tracers and the expression of tight junction proteins that are known to control paracellular permeability. Two tracers were utilized, fluorescein isothiocyanate-Dextran (**FD**, 4 kD) and horseradish peroxidase (**HRP**) with a molecular mass of 40 kD, similar to those of many antigenic food proteins.

Staphylococcal enterotoxin B treatment significantly increased the flux of FD across the intestinal wall, and the SDP and PPF supplements prevented this effect ([Figure 4](#F4){ref-type="fig"}). Staphyloccocal enterotoxin B also enhanced the HRP movement across the mucosa, and the supplements showed a tendency to prevent this effect. However, there was a significant positive correlation between FD and HRP flux values, indicating that the paracellular route contributes to increased protein translocation across the intestine in animals challenged with the enterotoxin. Staphyloccocal enterotoxin B reduced the expression of ZO-1 and β-catenin, and both proteins tended to be negatively correlated with FD flux, indicating that the increases in dextran flux are paralleled by reductions in ZO-1 and β-catenin expression at the epithelial level ([Figure 5](#F5){ref-type="fig"}). These results indicate that the increase in FD flux induced by SEB treatment is associated with a reduction in the tightness of the epithelial junction complex and that both dietary supplements resulted in some recovery ([Figure 5](#F5){ref-type="fig"}). The effects of SEB were similar to those described in SEB-injected mice ([@LU-ETAL-1998]). The effects of SDP and PPF supplementation on reducing toxin-induced increase in mucosal permeability may prevent the passage of microbial and food antigens to the interstitial space, thereby blocking local inflammation ([@SANTOS-ETAL-2001]).

![Effects of dietary supplementation with plasma concentrate (spray-dried plasma, SDP) and plasma protein fraction (PPF) on intestinal permeability of jejunum in a rat model of mild intestinal inflammation. Inflammation was induced by intraperitoneal administration of 50 μ g of *Staphylococcus aureus* enterotoxin B (SEB) on d 30 and 33 of age. Animals were fed experimental diets for 14 d. Intestinal permeability was estimated from the flux of FITC-dextran 4kDa (FD) across the whole intestinal wall in Ussing chambers. Results are mean ± SEM of 8 to 10 animals. Symbols indicate significant differences (*P* \< 0.05): \*vs. control group; §vs. SEB group (from [@PEREZ-BOSQUE-ETAL-2006]).](jas1381-f4){#F4}

![Effects of dietary supplementation with plasma concentrate (spray-dried plasma, SDP) and plasma protein fraction (PPF) on epithelial expression of ZO-1 and β-Catenin at intestinal level in a rat model of mild intestinal inflammation. Inflammation was induced by intraperitoneal administration of 50 μ g of *Staphylococcus aureus* enterotoxin (SEB) on d 30 and 33 of age. Animals were fed experimental diets for 14 d. Results are mean ± SEM of 8 to 10 animals. Symbols indicate significant differences (*P* \< 0.05): \*vs. control group; §vs. SEB group (from [@PEREZ-BOSQUE-ETAL-2006]).](jas1381-f5){#F5}

Proinflammatory cytokines are the main candidates for mediating these effects because they are induced by SEB ([@HUANG-AND-KOLLER-1998]; [@MCKAY-ETAL-1998]) and facilitate antigen flux across the paracellular space ([@TOIVOLA-ETAL-2004]). Consistent with these observations, toxins like SEB stimulate lymphocytes to secrete INF-γ and TNF-α, which can disassemble tight junction proteins ([@NUSRAT-ETAL-2000]) or reduce their expression ([@TSUKITA-ETAL-2002]; [@BRUEWER-ETAL-2003]). The resulting increased intestinal permeability can enhance local inflammation, as happens in ulcerative colitis and inflammatory bowel disease ([@MCKAY-2001]).

NUTRIENT ABSORPTION
===================

In farm animals, enteric infections may cause intestinal inflammation, villous atrophy, and malabsorption that contribute to high rates of mortality ([@VAN-DIJK-ETAL-2002]). The effects of intestinal inflammation on nutrient absorption have been studied in different animal models. In neonatal rats, *C. parvum* infection does not affect peptide transport ([@MARQUET-ETAL-2007]) but disrupts AA absorption, leading to undernutrition and growth reduction that is not restored by spontaneous clearance of the parasite ([@TOPOUCHIAN-ETAL-2001]). Lipopolysaccharide (**LPS**) inhibits intestinal absorption of D-galactose via a complex cellular mechanism that could involve posttranscriptional regulation of the brush-border Na^+^-coupled glucose and galactose transporter \[**SGLT1** ([@AMADOR-ETAL-2007])\]. Lipopolysaccharide also reduces the expression of mucosal glucose transporter 5, the brush-border specific fructose transporter, by a mechanism involving TNF-α ([@GARCIA-HERRERA-ETAL-2008]). Tumor necrosis factor-α inhibits D-fructose uptake in rabbit intestine ([@GARCIA-HERRERA-ETAL-2004]), whereas IFN-γ downregulates D-glucose transport in T84 cells ([@YOO-ETAL-2000]). These results support the view that cytokines produced during inflammatory processes are involved in control of expression of nutrient transport proteins.

Our results using the SEB model show that the enterotoxin did not affect the uptake rates of [l]{.smallcaps}-leucine, [l]{.smallcaps} -methionine, and [l]{.smallcaps} -lysine but reduced the capacity of the jejunum to transport D-glucose through SGLT1 ([@GARRIGA-ETAL-2005]). This effect was attributed to a reduction in the expression of D-glucose transporters in the brush border membrane, as indicated by the decreased V~max~ (the maximal transport capacity kinetic constant). This observation was supported by results from immunohistochemical analysis of SGLT1. Consistent with [@FERRARIS-ETAL-1990], immune staining of SGLT1 showed that the protein is present in absorptive epithelial cells along the crypt-villous axis, with greater expression in the upper villous region than in the mid and basal regions ([Figure 6](#F6){ref-type="fig"}). Therefore, it was concluded that the changes in D-glucose transport kinetics observed in rats challenged with SEB were due to specific effects on the function of SGLT1. In rats challenged with SEB, SDP increased SGLT1 maximal transport capacity. The effect of PPF was intermediate. This effect of SDP on SGLT1 expression was further confirmed by Western blot analysis ([@GARRIGA-ETAL-2005]).

![Effects of dietary supplementation with plasma concentrate (spray-dried plasma, SDP) and plasma protein fraction (PPF) on brush border expression of Na^+^-glucose transporter-1 (SGLT1) in the jejunum, in a rat model of mild intestinal inflammation. Inflammation was induced by intraperitoneal administration of 50 μ g of *Staphylococcus aureus* enterotoxin B (SEB) on d 30 and 33 of age. Animals were fed experimental diets for 14 d. Results are mean ± SEM of 8 to 10 animals. Symbols indicate significant differences (*P* \< 0.05): \*vs. control group; §vs. SEB group (from [@GARRIGA-ETAL-2005]).](jas1381-f6){#F6}

Although the mechanism of action of SDP is controversial, there is evidence that it reduces proinflammatory cytokine expression in GALT of early weaned piglets challenged with enterotoxigenic *E. coli* K88 ([@BOSI-ETAL-2004]). Furthermore, results from our laboratory indicate that plasma supplements may alter the mucosal balance of pro- and antiinflammatory cytokines ([@MORETO-ETAL-2008]). These results indicate that the effects of SDP on SGLT1 expression could be due to a reduction in mucosal proinflammatory cytokines. Mucosal proinflammatory cytokines have been shown to reduce SGLT1 expression in vivo ([@GARCIA-HERRERA-ETAL-2004], [@GARCIA-HERRERA-ETAL-2008]) and in vitro ([@YOO-ETAL-2000]).

[@GARRIGA-ETAL-2005] estimated that in control rats, at a physiological luminal D-glucose concentration of 50 mmol/L, 25% of total uptake would take place by the mediated mechanism and 75% by simple diffusion, whereas in SEB-challenged rats, these values would be 6 and 94%, respectively. If we assume that during interdigestive periods, typical luminal D-glucose concentration values are around 0.2 mmol/L ([@FERRARIS-ETAL-1990]), it can be calculated that SDP will increase the intestinal capacity to absorb D-glucose by 8 to 9%. This small but significant effect may contribute to the increase in growth and feed efficiency observed in farm animals fed SDP ([@COFFEY-AND-CROMWELL-2001]; [@VAN-DIJK-ETAL-2001]).

MODE OF ACTION
==============

The effects of SDP may be a direct effect improving food intake (e.g., by the greater palatability leading to increased feed intake; [@ERMER-ETAL-1994]) or the effect of SDP may be more indirect by other mechanisms at luminal, mucosal, and systemic levels. Luminal effects were suggested by [@VAN-DIJK-ETAL-2001] who reported an improvement in immunocompetence or a reduction in mucosal binding of luminal antigens by plasma glycoproteins.

More recent evidence indicates that the mechanism of action of SDP on growth performance involves regulation of GALT. In challenged pigs, [@BOSI-ETAL-2004] observed that the expression of proinflammatory cytokines was less in animals fed SDP. Results from our laboratory indicate that plasma supplements reduce the expression of mucosal proinflammatory cytokines ([@MORETO-ETAL-2008]) and the activation of T-helper subsets in the lamina propria and epithelium ([@PEREZ-BOSQUE-ETAL-2008B]). These effects on mucosal cytokine profile can explain the observed reduction of mucosal inflammation by plasma supplements and the preventive effects of SDP and PPF on changes in mucosal permeability ([@PEREZ-BOSQUE-ETAL-2004]), tight junction protein expression ([@PEREZ-BOSQUE-ETAL-2006]), and nutrient absorption ([@GARRIGA-ETAL-2005]) induced by SEB.

There are several possibilities by which SDP and PPF can modulate intestinal immune response. Plasma concentrate is a complex mixture of growth factors, cytokines, and other biologically active compounds. These proteins can interact with immune cells present in the mucosa, thus changing the cytokine environment. Finally, SDP affected more of the variables measured than did PPF, supporting the hypotheses that several of the proteins in SDP contribute to the effects of SDP ([Figure 7](#F7){ref-type="fig"}).

![Diagram summarizing the mode of action of plasma supplements \[spray-dried plasma, (SDP) or plasma protein fraction (PPF)\]. Food proteins and products from commensal bacteria can be taken up by M cells present in Peyer\'s patches, by dendritic cells (DC) of the lamina propria, or by transcytosis (especially at early stages of development). Antigens are then presented to naive CD4 T cells and activated. Activated lymphocytes produce proinflammatory cytokines that amplify the immune response and induce inflammatory cell recruitment. In an inflammatory state, immune cells release reactive oxygen species (ROS) to eliminate invaded pathogens; however, these agents also induced gut alterations and tissue destruction. Plasma protein supplementation can modulate the immune response at luminal level (e.g., modifying the microbiota profile, pathogen binding); biologically active compounds present in plasma supplements can also interact directly with mucosal immune cells. The plasma-induced changes in mucosal cytokine profile will prevent or reverse deleterious effects resulting from immune system activation. IEL = intraepithelial lymphocytes; T-reg = regulator T-lymphocytes; APC = antigen presenting cells; Th1 = T helper type 1; Th2 = T helper type 2.](jas1381-f7){#F7}

SUMMARY AND CONCLUSIONS
=======================

Spray-dried plasma reduces the overstimulation of the immune response in animals (e.g., pigs and rats) allowing more of the available energy and nutrients to be used for growth and other productive functions rather than being diverted to support the immune response. In the SEB-challenged rat experiencing mild intestinal inflammation, SDP reduced the production of mucosal proinflammatory cytokines and increased production of antiinflammatory cytokine IL-10. This supports the hypotheses that SDP reduces overstimulation of the mucosal immune response by enhancing IL-10 secretion.

It is worth noting that SDP also has systemic effects. For example, it can reduce the expression of proinflammatory cytokines in peripheral tissues of LPS-challenged pigs ([@TOUCHETTE-ETAL-2002]) and prevent the increase in activated lymphocyte populations in a LPS-induced lung inflammation model ([@PEREZ-BOSQUE-ETAL-2008A]). Because organized GALT is an inductive site that connects with both local and peripheral effecter sites (respiratory tracts, glandular tissues and the uterus mucosa), it can be further hypothesized that SDP may reduce overstimulation of the broader common mucosal immune system.
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